News
CRGT
10.00
0.00%
0.00
IPO Roundup: Smithfield Foods, Beta Bionics and more
Seeking Alpha · 01/27 14:50
Cortigent, Inc IPOs Tomorrow, Here's What You Need To Know
Benzinga · 01/23 15:00
U.S. IPO Weekly Recap: Oil And Gas Well Equipment Provider Flowco Debuts, While More Sizable Deals Join The Pipeline
Seeking Alpha · 01/18 05:30
Cortigent, Inc IPOs Tomorrow, Here's What You Need To Know
Benzinga · 01/14 15:00
U.S. IPO Weekly Recap: Flowco Launches First Major IPO Of 2025 As Smithfield, Others Join The Pipeline
Seeking Alpha · 01/11 05:20
Cortigent, Inc To Start Trading Tomorrow
Benzinga · 01/07 15:00
Delta Air Lines, Albertsons Are The First Big Names To Report Results In 2025
Seeking Alpha · 01/04 16:00
U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings
Seeking Alpha · 01/04 05:30
More
Webull provides a variety of real-time CRGT stock news. You can receive the latest news about Cortigent, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About CRGT
Cortigent, Inc. is engaged in developing targeted neurostimulation systems that help patients to recover critical body functions. Its technology combines advanced neuroscience with microelectronics, software, and data processing capabilities to provide artificial vision and potentially restore muscle movement. Its commercial system, Argus II, provides artificial vision to various profoundly blind people who were implanted with this device. It is further engaged in exploring the application of its Orion neurostimulation technology for accelerating the recovery of arm and hand function in patients who are partially paralyzed due to stroke. The Company is also engaged in developing a platform technology with multiple potential applications, which includes its miniature neurostimulation device with 60 independent-cortical stimulation channels, supported by data from the Argus II and Orion programs, which serves as a platform for targeting other conditions with high unmet medical need.